PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
2.95%
Net income growth under 50% of MCHP's 117.93%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
0.47%
Some D&A expansion while MCHP is negative at -5.42%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
75.00%
Well above MCHP's 135.89% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
48.00%
SBC growth well above MCHP's 2.91%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-572.34%
Negative yoy working capital usage while MCHP is 121.58%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-95.83%
AR is negative yoy while MCHP is 97.11%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-219.15%
Both reduce yoy inventory, with MCHP at -2233.33%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
120.37%
A yoy AP increase while MCHP is negative at -108.18%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-181.37%
Both reduce yoy usage, with MCHP at -18.07%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-500.00%
Both negative yoy, with MCHP at -82.15%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-9.04%
Negative yoy CFO while MCHP is 40.23%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
65.44%
Some CapEx rise while MCHP is negative at -55.78%. John Neff would see competitor possibly building capacity while we hold back expansions.
-97.06%
Both yoy lines negative, with MCHP at -100.00%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-7.87%
Negative yoy purchasing while MCHP stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
2.44%
Liquidation growth of 2.44% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
50.00%
We have some outflow growth while MCHP is negative at -78.32%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
25.17%
We have mild expansions while MCHP is negative at -78.32%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
100.00%
We repay more while MCHP is negative at -71.38%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
9.62%
We slightly raise equity while MCHP is negative at -39.30%. John Neff sees competitor possibly preserving share count or buying back shares.
-314.79%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.